Navigation Links
NYU-Poly Professor Among First Winners of BioAccelerate NYC Prize; Project May Move Diagnostic Medicine from the Lab to the Palm of a Hand
Date:5/3/2010

NEW YORK, May 3 /PRNewswire/ -- The future of diagnostic medicine may lie in an inexpensive credit card-sized device that requires no advanced training to operate, uses minimal power and provides high-accuracy detection of infectious diseases from a single patient sample in less than 30 minutes.

Dr. Kalle Levon, professor of chemical and biological science at Polytechnic Institute of New York University (NYU-Poly), is one critical step closer to turning this concept into reality as one of six winners of the first BioAccelerate NYC Prize, a $1.5 million grant created to fuel the growth of life science and biotech businesses in New York City.

Each BioAccelerate NYC winner will receive a $250,000 grant to conduct late-stage, proof-of-concept research on products to improve health and wellness. BioAccelerate NYC is a project of the Partnership for New York City and the New York City Economic Development Corporation (NYCEDC).

Dr. Levon's proposal -- the sole winner to address a diagnostic issue -- tackles the inefficiencies of infectious disease diagnostics including high cost, lengthy result times, bulky equipment and the need for large sample sizes and highly trained personnel.  

Uniting experts in polymer chemistry, electrical engineering and medical research, Dr. Levon has conceptualized a handheld, point-of-care device to detect infectious diseases using a patented floating gate field effect transistor (FGFET) biosensor.

This cost-effective biosensor utilizes readily available MOS transistors coated with a conductive polymer. When in contact with a small sample of body fluid, the polymer detects biological and chemical binding reactions with a high degree of sensitivity, translating these signals into electrical signals. A light on the device would indicate a positive or negative test result.  Due to small size, easy interpretation of results and low sample volume required, a technician with basic training could utilize the device in any clinical setting, no matter how rudimentary, anywhere in the world.

This field of study, known as organic electronics, has been applied to diagnostic techniques in research and academia for a decade, but Dr. Levon's team is the first to conceive a commercial application utilizing this technology.

"Our goal at NYU-Poly is to transform research outcomes into applications that solve 21st century problems," said NYU-Poly Provost Dr. Dianne Rekow. "Dr. Levon's work is an ideal example of our core philosophy, i-squared-e -- invention, innovation and entrepreneurship -- come to life. We salute the city for its support of a project that could benefit healthcare systems worldwide."

The BioAccelerate grant will facilitate the development of a complete prototype, created in partnership with The Brooklyn Hospital. The pilot will focus on chlamydia and gonorrhea detection, but the technique could be applied to any infectious disease, including H1N1 or HIV.

Previous lab tests proved the FGFET biosensor's efficacy in detecting a single biomarker, but Dr. Levon 's vision includes the creation of a scalable, multiplex array of sensors capable of testing for several agents simultaneously, as well as applications for cancer diagnostics.  

About Polytechnic Institute of New York University

Polytechnic Institute of New York University (formerly Polytechnic University), an affiliate of New York University, is one of New York City's most comprehensive schools of engineering, applied sciences, technology, and research, and is rooted in a 156-year tradition of invention, innovation, and entrepreneurship: i-squared-e.

The institution, founded in 1854, is one of the nation's oldest private engineering schools. In addition to its main campus at MetroTech Center in downtown Brooklyn, it offers programs at sites throughout the region and around the globe. NYU-Poly has centers in Long Island, Manhattan and Westchester County; globally, it has programs in Israel, China and will be an integral part of NYU's campus in Abu Dhabi opening in autumn 2010.

For more information, visit www.poly.edu.

Downloadable photo at http://www.poly.edu/about/press/releases


'/>"/>
SOURCE Polytechnic Institute of New York University
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. InteKrin Therapeutics Co-Founder Receives Appointment as Professor of Medicine at Harvard Medical School
2. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
3. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
4. Limited Healthcare Infrastructure and Weak Intellectual Property Protection are Among the Challenges Pharma Faces with Emerging Market Expansion
5. New Study Links dLife to Increased Rx Drug Usage Among Diabetes Consumers
6. Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network
7. Native Remedies NutraRx Brand of Natural Products for Medical Practitioners Among First to Earn Prestigious Emerson EQP Seal
8. Aurora Hospitals Named Among the Nations Best
9. A Drugs Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections
10. At Nearly $120 Million, The Hepatitis C Drug Market in Brazil is Among the Largest Emerging Pharmaceutical Markets for the Disease
11. The Scientist Magazine Recognizes febits HybSelect(TM) Among the Winners of Top 10 Innovations of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
(Date:6/23/2016)... Pa. , June 23, 2016 The ... in an outpatient dialysis facility.  Treatments are usually 3 ... 6 hours per visit, including travel time, equipment preparation ... a patient, but especially grueling for patients who are ... of a skilled nursing and rehabilitation centers for some ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American Institutes ... Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , ... advance care planning, healthcare costs and patient and family engagement. , AIR researchers ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
Breaking Medicine News(10 mins):